Expansion to Annual Production Exceeding 1 Trillion Won
Accelerating Global Market Development in China and Southeast Asia

At the completion ceremony of the Chong Kun Dang Health Dangjin new factory held on the 23rd in Hapdeok-eup, Dangjin-si, Chungnam, attendees are participating in a ribbon-cutting ceremony.

At the completion ceremony of the Chong Kun Dang Health Dangjin new factory held on the 23rd in Hapdeok-eup, Dangjin-si, Chungnam, attendees are participating in a ribbon-cutting ceremony.

View original image


[Asia Economy Reporter Lee Gwan-joo] Chong Kun Dang Health held a completion ceremony for its new factory in Hapdeok-eup, Dangjin-si, Chungnam Province on the 23rd. The new factory is the largest health functional food production facility in Korea.


The Dangjin new factory was constructed with an investment of 130 billion KRW and has a total floor area of 41,119㎡. It was established as a smart factory equipped with the country's largest dedicated probiotic production line, state-of-the-art soft capsule manufacturing line, and automated production lines for liquid products such as red ginseng, along with the latest equipment and monitoring systems.


The concept of the Dangjin new factory is "a new landmark never seen before," with the exterior designed based on Korean nature motifs such as mountains, water, and bamboo forests to harmonize with the natural scenery of Dangjin.


Chong Kun Dang Health Dangjin New Factory.

Chong Kun Dang Health Dangjin New Factory.

View original image

Inside, a multipurpose space called "Welcome Stair" was prepared for in-house meetings, seminars, and hosting guests. Facilities for employees include a fitness center, table tennis room, screen golf facilities, and training rooms. On the 5th floor of the building, a restaurant and cafe with a view operate so that employees can enjoy meals and leisure time while appreciating the surrounding scenery.


Chong Kun Dang Health expects that with the completion of this new factory, the annual production capacity will expand from the existing scale of 250 billion KRW to over 1 trillion KRW.



Kim Ho-gon, CEO of Chong Kun Dang Health, said, "With the completion of the Dangjin new factory, we will appropriately respond to the rapidly increasing demand for major products such as 'Lactofit,' 'Promega,' and 'iClear,' meeting consumers' needs for a healthy life." He added, "We will strengthen market competitiveness with more differentiated products and actively target the global market starting with China and Southeast Asia."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing